Cidara Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that Jeffrey Stein, Ph.D., President and Chief Executive Officer, is scheduled to participate in the following upcoming investor conferences.

Event: Cantor Fitzgerald Future of Oncology Virtual SymposiumFormat: Panel DiscussionDate: Monday, April 3, 2023Time: 11:00am ET

Event: 22nd Annual Needham Virtual Healthcare ConferenceFormat: Presentation and 1x1 Investor MeetingsDate: Monday, April 17, 2023Time: 12:45pm ET Webcast: https://wsw.com/webcast/needham129/cdtx/2262858

Cidara’s presentation at the Needham Conference will be available on-demand from the above date/time in the investors section on the Company’s website at www.cidara.com. The replay of the presentation will be available for 90 days.

About Cidara TherapeuticsCidara is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The company’s portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including drug-Fc conjugates (DFCs) from its proprietary Cloudbreak® platform targeting oncologic and viral diseases. In addition, Cidara recently received FDA approval for REZZAYO™ (rezafungin for injection), which it has licensed to multiple partners to commercialize in the U.S. and ex-U.S. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.

INVESTOR CONTACT:Brian RitchieLifeSci Advisors(212) 915-2578[email protected]

MEDIA CONTACT:Veronica EamesLifeSci Communications(646) 970-4682[email protected]

You May Also Be Interested In

• Hawk Law Group’s Hawk Helps Hosts Third Annual Bookbag Bash, Providing Back-to-School Supplies to More Than 500 Augusta-Area Students
• How to Pick a Broker Who Actually Knows the Market
• Best 2 MOPP Medical Power Supplies: WECENT Promotes Evidence-Based Isolation Selection for Medical Device Sourcing